| Dr William B Aarons Jr, MD | |
|
1925 Pacific Ave, Armc, Atlantic City, NJ 08401-6713 | |
| (609) 441-8151 | |
| Not Available |
| Full Name | Dr William B Aarons Jr |
|---|---|
| Gender | Male |
| Speciality | Surgery |
| Location | 1925 Pacific Ave, Atlantic City, New Jersey |
| Accepts Medicare Assignments | Does not participate in Medicare Program. He may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1972551240 | NPI | - | NPPES |
| 2367602 | Medicaid | NJ |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 208600000X | Surgery | 25MA03199400 (New Jersey) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Dr William B Aarons Jr, MD 1925 Pacific Ave, Armc, Atlantic City, NJ 08401-6713 Ph: (609) 441-8151 | Dr William B Aarons Jr, MD 1925 Pacific Ave, Armc, Atlantic City, NJ 08401-6713 Ph: (609) 441-8151 |
News Archive
A study published in the August issue of Cancer Research has resulted in several premature and potentially misleading conclusions when it comes to fructose and its effect on pancreatic tumor cells. Unfortunately, the media covering this story, and even the authors, have been too quick to extrapolate the results of laboratory research on pure fructose to real-world conditions, which is not appropriate or helpful to consumers.
Medivation, Inc. and Astellas Pharma Inc. today announced treatment of the first patient in a second Phase 3 clinical trial of the investigational drug MDV3100, which expands the Phase 3 development of the novel, triple-acting oral androgen receptor antagonist into an earlier-stage patient population. Known as PREVAIL, the trial will evaluate MDV3100 in men with advanced prostate cancer who have not yet received chemotherapy. Initiation of the PREVAIL trial triggers a milestone payment to Medivation under its collaboration agreement with Astellas.
ReCor Medical, an emerging medical device company, reported today six-month follow-up data on eight patients who have been treated via renal denervation for their resistant hypertension with the Company's PARADISE System—the only system for renal denervation that is based on ultrasound, not radiofrequency, energy.
A drug to treat colon cancer is proving much more convenient than traditional chemotherapy, has fewer side effects - and a study of almost 2,000 patients has shown it is giving them a better chance of surviving the disease.
› Verified 5 days ago
Kelly Marie Willman, M.D. Surgery Medicare: Accepting Medicare Assignments Practice Location: 1925 Pacific Ave, Trauma Department, Atlantic City, NJ 08401 Phone: 609-441-8023 Fax: 609-441-8178 | |
Richard K Burns, MD Surgery Medicare: Accepting Medicare Assignments Practice Location: 1925 Pacific Ave, Atlantic City, NJ 08401 Phone: 609-441-8023 Fax: 609-441-8173 | |
Dr. Alexander Axelrad, MD Surgery Medicare: Accepting Medicare Assignments Practice Location: 1925 Pacific Ave, Atlantic City, NJ 08401 Phone: 609-441-8023 | |
David A Stidd, MD Surgery Medicare: Accepting Medicare Assignments Practice Location: 1925 Pacific Ave, 1st Floor, Atlantic City, NJ 08401 Phone: 609-572-8600 Fax: 609-572-8667 | |
Ayoola Olaoluwa Ali, M.D. Surgery Medicare: Accepting Medicare Assignments Practice Location: 1925 Pacific Ave, Atlantic City, NJ 08401 Phone: 609-441-8023 |